Fertility Preservation in Female Cancer Patients: Our Center Experiences

Reproductive options are one of the most important issues to cancer survivors, and it is related to quality of life. Although most of young patients are interested in parenthood in future but significantly pretreatment access of patients to fertility preservation (FP) services is low, because of low referral rate and disparity. Data were retrospectively analyzed from 77 cancer patients who were referred to vali-e-asr reproductive center between March 2013 and February 2015. Their ovarian reserve was estimated with AMH test, Antral follicular count and FSH (if they were referred in first days of menstrual cycle). Embryo or oocyte cryopreservation was used based on participants' marriage status. Of 77(mean age 30, range: 16-45) patients 29(37.2%) were declined fertility preservation and the cost was the most frequent prohibitive cause. 10(12.9%) were excluded of fertility preservation services. Of 38 patients who were recruited for fertility preservation, 28(60.5%) were married, the mean number of embryos cryopreserved were 3.9. and the mean number of oocytes cryopreserved for 10 single participant in this group was 5.7. Our results demonstrate that oncologists have essential role in improving the provision of fertility preservation services. There are different available FP options that they can be use individualize. By assessing patients' prohibitive factor and making an attempt to diminish them such as cost of FP services, we can improve their quality of life.